Clinical

Dataset Information

Tislelizumab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With Advanced CRC


ABSTRACT: A Phase II Study to Assess the Efficacy and Safety of Tislelizumab Combined With Fruquintinib and SBRT as A third-line and Posterior Line Treatment in Patients With Advanced Colorectal Cancer

DISEASE(S): Colorectal Neoplasms,Patients With Advanced Metastatic Colorectal Cancer

PROVIDER: 2380401 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR